Veralto Co. (NYSE:VLTO) Shares Bought by Toronto Dominion Bank

Toronto Dominion Bank boosted its holdings in shares of Veralto Co. (NYSE:VLTO - Free Report) by 11.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 123,559 shares of the company's stock after acquiring an additional 12,350 shares during the quarter. Toronto Dominion Bank's holdings in Veralto were worth $13,821,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the business. State Street Corp raised its stake in shares of Veralto by 9.8% during the third quarter. State Street Corp now owns 9,599,499 shares of the company's stock valued at $1,074,654,000 after acquiring an additional 860,608 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Veralto by 207.2% during the 3rd quarter. Principal Financial Group Inc. now owns 1,122,898 shares of the company's stock worth $125,608,000 after purchasing an additional 757,389 shares during the period. Geode Capital Management LLC raised its position in Veralto by 10.5% during the 3rd quarter. Geode Capital Management LLC now owns 5,868,620 shares of the company's stock valued at $654,232,000 after purchasing an additional 558,393 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Veralto by 29.0% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 1,864,038 shares of the company's stock worth $208,511,000 after buying an additional 418,588 shares during the period. Finally, Point72 Asset Management L.P. bought a new position in shares of Veralto during the 2nd quarter worth $24,618,000. Institutional investors own 91.28% of the company's stock.

Veralto Stock Down 1.5 %

Shares of Veralto stock traded down $1.57 during trading on Friday, reaching $104.22. The company's stock had a trading volume of 756,295 shares, compared to its average volume of 1,199,955. Veralto Co. has a 1-year low of $73.91 and a 1-year high of $115.00. The company has a 50-day simple moving average of $107.02 and a two-hundred day simple moving average of $105.29. The company has a quick ratio of 1.87, a current ratio of 2.13 and a debt-to-equity ratio of 1.35. The company has a market cap of $25.77 billion, a price-to-earnings ratio of 32.17, a P/E/G ratio of 4.30 and a beta of 0.91.

Veralto (NYSE:VLTO - Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.85 by $0.04. The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.30 billion. Veralto had a net margin of 15.69% and a return on equity of 52.85%. Veralto's revenue was up 4.7% on a year-over-year basis. During the same period last year, the firm posted $0.75 EPS. As a group, equities analysts forecast that Veralto Co. will post 3.48 earnings per share for the current year.

Veralto Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Friday, September 27th were given a dividend of $0.09 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.36 dividend on an annualized basis and a yield of 0.35%. Veralto's dividend payout ratio is currently 11.11%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Royal Bank of Canada lifted their price objective on Veralto from $108.00 to $111.00 and gave the company a "sector perform" rating in a report on Friday, October 25th. Jefferies Financial Group initiated coverage on shares of Veralto in a report on Thursday. They issued a "buy" rating and a $125.00 price target for the company. Stifel Nicolaus dropped their price objective on shares of Veralto from $119.00 to $117.00 and set a "buy" rating on the stock in a research note on Wednesday. Finally, BMO Capital Markets boosted their price objective on shares of Veralto from $117.00 to $119.00 and gave the stock an "outperform" rating in a research note on Monday, September 30th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $109.50.

Insider Buying and Selling at Veralto

In related news, SVP Surekha Trivedi sold 753 shares of the business's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $112.55, for a total transaction of $84,750.15. Following the completion of the transaction, the senior vice president now directly owns 11,165 shares in the company, valued at $1,256,620.75. The trade was a 6.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jennifer Honeycutt sold 13,190 shares of the company's stock in a transaction on Monday, September 30th. The shares were sold at an average price of $110.15, for a total transaction of $1,452,878.50. Following the completion of the sale, the chief executive officer now directly owns 138,546 shares in the company, valued at approximately $15,260,841.90. The trade was a 8.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 14,695 shares of company stock worth $1,615,017. 0.31% of the stock is currently owned by insiders.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.